Ittai Harel is a Managing Partner with Pitango HealthTech Fund, where he has been leading healthcare and life-science investments for the past 17 years, with a focus on digital health, medical devices, biopharma, and diagnostics. Previously, Ittai headed corporate development and strategy at Nektar Therapeutics (NASDAQ: NKTR) and served as EVP at IDGene Pharmaceuticals. He also served as head of BD, corporate development, strategic planning and M&A, and as GM Europe at IDEXX Laboratories (NASDAQ: IDXX), after IDEXX acquired his MIT-based startup. Ittai serves on the BOD of QuantHealth.ai, Laguna, ProtAI, Altesa, Homethrive, Connie Health, TScan (NASDAQ:TCRX), Visby Medical, Incredo, Clew Medical, Medisafe, and the recently acquired - Vertos Medical. He holds a B.Sc. in Chemical Engineering and Biotechnology from Ben-Gurion University, and an MBA from the MIT Sloan School of Management